Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 9—September 2022
Research

Detecting Mycobacterium tuberculosis Infection in Children Migrating to Australia

Ingrid Laemmle-RuffComments to Author , Stephen M. Graham, Bridget Williams, Danielle Horyniak, Suman S. Majumdar, Georgia A. Paxton, Lila V. Soares Caplice, Margaret E. Hellard, and James M. Trauer
Author affiliations: Burnet Institute, Melbourne, Victoria, Australia (I. Laemmle-Ruff, S.M. Graham, B. Williams, D. Horyniak, S.S. Majumdar, M.E. Hellard, J.M. Trauer); Royal Children’s Hospital, Melbourne (I. Laemmle-Ruff, S.M. Graham, G.A. Paxton); University of Melbourne, Melbourne (S.M. Graham, S.S. Majumdar, G.A. Paxton, M.E. Hellard, J.M. Trauer); Monash University, Melbourne (D. Horyniak, S.S. Majumdar, M.E. Hellard, J.M. Trauer); The Alfred Hospital, Melbourne (S.S. Majumdar, M.E. Hellard, J.M. Trauer); Department of Home Affairs, Australian Government, Canberra, Australian Capital Territory, Australia (L.V.S. Caplice)

Main Article

Table 2

IGRA and TST testing and positivity in visa applicants <15 years of age migrating to Australia, November 2015–June 2017*

Characteristic
All applicants
Applicants tested by IGRA or TST
Applicants tested,
excluding missing/indeterminate results†
IGRA or TST positivity in applicants tested
Total
134,759 (100)
45,060 (33.4)
44,841
1,513 (3.4)
Sex
F 65,462 (48.6) 22,133 (33.8) 22,028 763 (3.5)
M
69,284 (51.4)
22,925 (33.1)
22,811
750 (3.3)
Age group, y
<4 62,646 (46.5) 18,503 (29.5) 18,410 505 (2.7)
5–9 40,357 (30.0) 22,615 (56.0) 22,509 796 (3.5)
10–14
31,756 (23.6)
3,942 (12.4)
3,922
212 (5.4)
Visa stream
Permanent 72,610 (53.9) 30,474 (42.0) 30,349 1,144 (3.8)
Temporary 45,490 (33.8) 4,466 (9.8) 4,430 160 (3.6)
Humanitarian
16,659 (12.36)
10,120 (60.8)
10,062
209 (2.1)
Region of origin
Oceania‡ 10,704 (7.9) 2,512 (23.5) 2,490 32 (1.3)
Northwest Europe 7,339 (5.5) 255 (3.5) 255 7 (2.8)
Southern and Eastern Europe 2,153 (1.6) 419 (19.5) 417 36 (8.6)
North Africa and Middle East 14,316 (10.6) 6,981 (48.8) 6,950 128 (1.8)
Southeast Asia 21,993 (16.3) 7,597 (34.5) 7,562 574 (7.6)
Northeast Asia 19,667 (14.6) 5,788 (29.4) 5,755 134 (2.3)
Southern and Central Asia 37,741 (28.0) 15,046 (39.9) 15,009 435 (2.9)
Americas 4,363 (3.2) 503 (11.5) 498 11 (2.2)
Sub-Saharan Africa 8,556 (6.4) 3,557 (41.6) 3,522 97 (2.8)
Missing/Inadequately described
7,927 (5.9)
2,402 (30.0)
2,383
59 (2.5)
Top 5 countries of origin, excluding Australia
India 25,208 9,860 (39.1) 9,831 317 (3.2)
China 14,013 4,703 (33.6) 4,680 114 (2.4)
Philippines 8,684 3,234 (37.2) 3,222 436 (13.5)
United Kingdom 5,562 170 (3.1) 170 5 (2.9)
Pakistan
5,175
2,472 (47.8)
2,471
24 (1.0)
Reported risk factors
Reported contact with TB 748 310 (41.4) 306 46 (15)
Previous treatment for TB
402
121 (30.1)
121
31 (25.6)
Test type No. (%) tests completed§
No. tests, excluding indeterminate
No. (%) positive tests
All 45,345 45,171 1,563 (3.5)
IGRA 26,171 (57.7) 25,997 532 (2.0)
TST 19,174 (42.3) 19,174 1,031 (5.4)

*Values are no. (%) except as indicated. Missing results across all applicants (excluded from corresponding demographic denominators): age not recorded for 7 applicants, none of whom were screened (excluded from entire analysis); gender not recorded for 13 applicants, reported TB contact not recorded for 7,645 applicants, previous treatment for TB not recorded for 13,484 applicants. Humanitarian visa holders, while considered as a separate visa application stream by the Department of Home Affairs, have permanent residency in Australia. IGRA, interferon-gamma release assay; TST, tuberculin skin test; TB, tuberculosis disease. †Applicants who had IGRA or TST but with an indeterminate (IGRA, n = 174) or missing result (n = 45) excluded from column. ‡Oceania region includes 8,358 applicants with country of origin as Australia (8,018 born in Australia). This reflects children born in Australia of families applying for migration. No further information regarding parental country of origin available. §Total of 45,345 IGRAs and TSTs conducted with 330 applicants with >1 test in an application (227 with 2 tests and 3 with 3 tests).

Main Article

Page created: July 14, 2022
Page updated: August 19, 2022
Page reviewed: August 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external